
Overview
Melissa Burgess, MD, is an assistant professor at the University of Pittsburgh School of Medicine and a medical oncologist. She specializes in the treatment of soft tissue and bone sarcomas and Merkel cell carcinoma.
Dr. Burgess is highly rated in 41 conditions, according to our data. Her clinical expertise encompasses Adult Soft Tissue Sarcoma, Liposarcoma, Merkel Cell Carcinoma, Chondrosarcoma, and Gamma Knife Radiosurgery.
Dr. Burgess is board certified in American Board Of Internal Medicine. She is actively involved in clinical research, co-authoring 40 peer reviewed articles and participating in 27 clinical trials. Dr. Burgess is currently accepting new patients.
Graduate Year
Specialties
Licenses
Board Certifications
Fellowships
Hospital Affiliations
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- HMO
- MANAGED MEDICAID PLAN
- MEDICARE SNP
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE SNP
- OTHER MEDICARE PART D
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- POS
- PPO
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE PART D
- HMO
- MANAGED MEDICAID PLAN
- EPO
- HMO
- POS
- PPO
- EPO
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
5115 Centre Avenue, Hillman Cancer Center, Pittsburgh, PA 15232
Additional Areas of Focus
Dr. Burgess has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
26 Clinical Trials
UPMC Hillman Cancer Center
Adam M. Brufsky, MD, PhD, FACP, is professor of medicine at the University of Pittsburgh School of Medicine and also serves as the associate division chief for the Division of Hematology/Oncology at the University of Pittsburgh School of Medicine's Department of Medicine. Dr. Brufsky is the medical director of the Magee-Women's Cancer Program, part of the UPMC Hillman Cancer Center, and UPMC Hillman Cancer Center; associate director for clinical investigations at UPMC Hillman Cancer Center; and codirector of the Comprehensive Breast Cancer Center.Dr. Brufsky is board-certified in internal medicine and medical oncology. He earned a medical and doctor of philosophy degrees from the University of Connecticut School of Medicine in Farmington, Conn.; completed a residency at Brigham and Women's Hospital, Harvard Medical School, and a fellowship at Dana-Farber Cancer Institute.Dr. Brufsky is a member of professional organizations, such as American Medical Association, Massachusetts Medical Society, American College of Physicians, American Society of Clinical Oncology, American Association for Cancer Research, Allegheny County Medical Society, Pennsylvania Medical Society, and Pennsylvania Oncologic Society. An active researcher, Dr. Brufsky has numerous abstracts and research articles in leading journals, and is principal investigator on a number of research grants funded by the National Institutes of Health, Susan G. Komen Foundation, and US Army - Breast Cancer Research Program. Dr. Brufsky is highly rated in 16 conditions, according to our data. His clinical expertise encompasses Breast Cancer, Triple-Negative Breast Cancer, Inflammatory Breast Cancer, Breast Cancer in Men, and Gastrostomy. Dr. Brufsky is board certified in American Board Of Internal Medicine and American Board Of Internal Medicine. Dr. Brufsky is currently accepting new patients.
UPMC Hillman Cancer Center
Liza C. Villaruz, MD, is board-certified in medical oncology and hematology at UPMC Hillman Cancer Center, and she specializes in lung cancer and thoracic malignancies. Dr. Villaruz is highly rated in 13 conditions, according to our data. Her clinical expertise encompasses Non-Small Cell Lung Cancer (NSCLC), Lung Cancer, EGFR Positive Lung Cancer, and Small Cell Lung Cancer (SCLC). Dr. Villaruz is board certified in American Board Of Internal Medicine. Dr. Villaruz is currently accepting new patients.
UPMC Hillman Cancer Center
Shirley Ong, MD, specializes in hematology oncology and is board-certified in neurology by the American Board of Psychiatry and Neurology. She practices at UPMC Hillman Cancer Center and is affiliated with UPMC Shadyside and UPMC Presbyterian. Dr. Ong received her medical degree from the University of the East Ramon Magsaysay Memorial Medical Center and completed her residency at Saint Louis University School of Medicine, followed by a fellowship at the University of Texas MD Anderson Cancer Center. Dr. Ong is highly rated in 16 conditions, according to our data. Her clinical expertise encompasses Glioblastoma, Astrocytoma, Glioma, and Brain Tumor. Dr. Ong is board certified in American Board Of Psychiatry And Neurology. Dr. Ong is currently accepting new patients.
Frequently Asked Questions about Dr. Melissa A. Burgess
How do I make an appointment with Dr. Melissa A. Burgess?
You can book an appointment with Dr. Melissa A. Burgess by calling their office at 412-623-4759. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Melissa A. Burgess a top-rated expert for Adult Soft Tissue Sarcoma?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Melissa A. Burgess is classified as an Elite expert for Adult Soft Tissue Sarcoma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Melissa A. Burgess specialize in?
While Dr. Melissa A. Burgess is a Hematology Oncology, they have specific expertise in Adult Soft Tissue Sarcoma, Liposarcoma, and Merkel Cell Carcinoma. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Hematology Oncology.
Does Dr. Melissa A. Burgess participate in research or clinical trials?
Yes. Dr. Melissa A. Burgess has published 40 articles and abstracts on conditions like Adult Soft Tissue Sarcoma. You can view a list of Dr. Melissa A. Burgess's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. Melissa A. Burgess accept my insurance?
Dr. Melissa A. Burgess accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 412-623-4759 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- Adult Soft Tissue SarcomaDr. Burgess isElite. Learn about Adult Soft Tissue Sarcoma.
- Alveolar Soft Part SarcomaDr. Burgess isElite. Learn about Alveolar Soft Part Sarcoma.
- ChondrosarcomaDr. Burgess isElite. Learn about Chondrosarcoma.
- LiposarcomaDr. Burgess isElite. Learn about Liposarcoma.
- Merkel Cell CarcinomaDr. Burgess isElite. Learn about Merkel Cell Carcinoma.
- Synovial SarcomaDr. Burgess isElite. Learn about Synovial Sarcoma.
- Distinguished
- AngiosarcomaDr. Burgess isDistinguished. Learn about Angiosarcoma.
- Bone TumorDr. Burgess isDistinguished. Learn about Bone Tumor.
- Desmoplastic Small Round Cell TumorDr. Burgess isDistinguished. Learn about Desmoplastic Small Round Cell Tumor.
- Epithelioid SarcomaDr. Burgess isDistinguished. Learn about Epithelioid Sarcoma.
- Ewing SarcomaDr. Burgess isDistinguished. Learn about Ewing Sarcoma.
- FibrosarcomaDr. Burgess isDistinguished. Learn about Fibrosarcoma.
- GanglioneuroblastomaDr. Burgess isDistinguished. Learn about Ganglioneuroblastoma.
- GanglioneuromaDr. Burgess isDistinguished. Learn about Ganglioneuroma.
- MesenchymomaDr. Burgess isDistinguished. Learn about Mesenchymoma.
- Myxoid LiposarcomaDr. Burgess isDistinguished. Learn about Myxoid Liposarcoma.
- OsteosarcomaDr. Burgess isDistinguished. Learn about Osteosarcoma.
- Retroperitoneal LiposarcomaDr. Burgess isDistinguished. Learn about Retroperitoneal Liposarcoma.
- Rhabdoid TumorDr. Burgess isDistinguished. Learn about Rhabdoid Tumor.
- Rhabdoid Tumor Predisposition SyndromeDr. Burgess isDistinguished. Learn about Rhabdoid Tumor Predisposition Syndrome.
- RhabdomyosarcomaDr. Burgess isDistinguished. Learn about Rhabdomyosarcoma.
- Rhabdomyosarcoma EmbryonalDr. Burgess isDistinguished. Learn about Rhabdomyosarcoma Embryonal.
- Undifferentiated Pleomorphic SarcomaDr. Burgess isDistinguished. Learn about Undifferentiated Pleomorphic Sarcoma.
- Advanced
- Angiosarcoma of the LiverDr. Burgess isAdvanced. Learn about Angiosarcoma of the Liver.
- Angiosarcoma of the ScalpDr. Burgess isAdvanced. Learn about Angiosarcoma of the Scalp.
- AstrocytomaDr. Burgess isAdvanced. Learn about Astrocytoma.
- Atypical Teratoid Rhabdoid Tumor (ATRT)
- ChordomaDr. Burgess isAdvanced. Learn about Chordoma.
- Congenital Generalized FibromatosisDr. Burgess isAdvanced. Learn about Congenital Generalized Fibromatosis.
- Desmoid TumorDr. Burgess isAdvanced. Learn about Desmoid Tumor.
- EpendymomaDr. Burgess isAdvanced. Learn about Ependymoma.
- Gastrointestinal Stromal TumorDr. Burgess isAdvanced. Learn about Gastrointestinal Stromal Tumor.
- GlioblastomaDr. Burgess isAdvanced. Learn about Glioblastoma.
- GliosarcomaDr. Burgess isAdvanced. Learn about Gliosarcoma.
- Infantile MyofibromatosisDr. Burgess isAdvanced. Learn about Infantile Myofibromatosis.
- Malignant Peripheral Nerve Sheath Tumor
- MelanomaDr. Burgess isAdvanced. Learn about Melanoma.
- OligodendrogliomaDr. Burgess isAdvanced. Learn about Oligodendroglioma.
- Pediatric Low-Grade Glioma (pLGG)Dr. Burgess isAdvanced. Learn about Pediatric Low-Grade Glioma (pLGG).
- Posterior Fossa TumorDr. Burgess isAdvanced. Learn about Posterior Fossa Tumor.
- Primitive Neuroectodermal Tumor (PNET)
- Experienced
- Adenoid Cystic CarcinomaDr. Burgess isExperienced. Learn about Adenoid Cystic Carcinoma.
- Adrenal CancerDr. Burgess isExperienced. Learn about Adrenal Cancer.
- AgranulocytosisDr. Burgess isExperienced. Learn about Agranulocytosis.
- ALK-Positive Non-Small Cell Lung CancerDr. Burgess isExperienced. Learn about ALK-Positive Non-Small Cell Lung Cancer.
- Brain TumorDr. Burgess isExperienced. Learn about Brain Tumor.
- Cholangiocarcinoma (Bile Duct Cancer)Dr. Burgess isExperienced. Learn about Cholangiocarcinoma (Bile Duct Cancer).
- Choroid Plexus PapillomaDr. Burgess isExperienced. Learn about Choroid Plexus Papilloma.
- Chronic Familial NeutropeniaDr. Burgess isExperienced. Learn about Chronic Familial Neutropenia.
- Clear Cell SarcomaDr. Burgess isExperienced. Learn about Clear Cell Sarcoma.
- DehydrationDr. Burgess isExperienced. Learn about Dehydration.
- Diencephalic SyndromeDr. Burgess isExperienced. Learn about Diencephalic Syndrome.
- Diffuse Midline Glioma H3 K27M-MutantDr. Burgess isExperienced. Learn about Diffuse Midline Glioma H3 K27M-Mutant.
- Eccrine PorocarcinomaDr. Burgess isExperienced. Learn about Eccrine Porocarcinoma.
- EGFR Positive Lung CancerDr. Burgess isExperienced. Learn about EGFR Positive Lung Cancer.
- Gamma Knife RadiosurgeryDr. Burgess isExperienced. Learn about Gamma Knife Radiosurgery.
- GliomaDr. Burgess isExperienced. Learn about Glioma.
- Hereditary NeuroblastomaDr. Burgess isExperienced. Learn about Hereditary Neuroblastoma.
- Large-Cell Lung CarcinomaDr. Burgess isExperienced. Learn about Large-Cell Lung Carcinoma.
- Legius SyndromeDr. Burgess isExperienced. Learn about Legius Syndrome.
- Lung AdenocarcinomaDr. Burgess isExperienced. Learn about Lung Adenocarcinoma.
- Lung CancerDr. Burgess isExperienced. Learn about Lung Cancer.
- Malignant Mixed Mullerian TumorDr. Burgess isExperienced. Learn about Malignant Mixed Mullerian Tumor.
- Metastatic Brain TumorDr. Burgess isExperienced. Learn about Metastatic Brain Tumor.
- Neural Crest TumorDr. Burgess isExperienced. Learn about Neural Crest Tumor.
- NeuroblastomaDr. Burgess isExperienced. Learn about Neuroblastoma.
- NeuroepitheliomaDr. Burgess isExperienced. Learn about Neuroepithelioma.
- NeurofibromatosisDr. Burgess isExperienced. Learn about Neurofibromatosis.
- Non-Small Cell Lung Cancer (NSCLC)Dr. Burgess isExperienced. Learn about Non-Small Cell Lung Cancer (NSCLC).
- Pleuropulmonary BlastomaDr. Burgess isExperienced. Learn about Pleuropulmonary Blastoma.
- Pseudomyxoma PeritoneiDr. Burgess isExperienced. Learn about Pseudomyxoma Peritonei.
- Renal Cell Carcinoma (RCC)Dr. Burgess isExperienced. Learn about Renal Cell Carcinoma (RCC).
- Severe Congenital NeutropeniaDr. Burgess isExperienced. Learn about Severe Congenital Neutropenia.
- Small Cell Lung Cancer (SCLC)Dr. Burgess isExperienced. Learn about Small Cell Lung Cancer (SCLC).
- Solitary Fibrous TumorDr. Burgess isExperienced. Learn about Solitary Fibrous Tumor.
- Squamous Cell Lung CarcinomaDr. Burgess isExperienced. Learn about Squamous Cell Lung Carcinoma.
- Urothelial CancerDr. Burgess isExperienced. Learn about Urothelial Cancer.


